GOVX

GeoVax Labs (GOVX)

About GeoVax Labs (GOVX)

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Details

Daily high
$2.38
Daily low
$2.19
Price at open
$2.31
52 Week High
$11.18
52 Week Low
$1.09
Market cap
21.6M
Dividend yield
0.00%
Volume
641,631
Avg. volume
707,277
P/E ratio
-.25

GeoVax Labs News

Details

Daily high
$2.38
Daily low
$2.19
Price at open
$2.31
52 Week High
$11.18
52 Week Low
$1.09
Market cap
21.6M
Dividend yield
0.00%
Volume
641,631
Avg. volume
707,277
P/E ratio
-.25